News Marking Rare Disease Day, FDA and patient group launch colla... The FDA has marked today’s international Rare Disease Day with a number of measures to promote research and patient participation in policy and research.
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face